tolterodine tartrate

Poland

Drugs containing this active substance

  • DEFUR

    The medicine is used to treat the symptoms of overactive bladder syndrome, such as sudden and/or frequent urination and urge incontinence.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 4 mg

    ATC: G04BD07

    Manufacturer: Merckle GmbH Pharmacare Premium Ltd. Pharmacie B.V. Pharmadox Healthcare, Ltd. Pharmathen International S.A. Pharmathen S.A. Teva Operations Polska Sp. z o.o. Teva Pharma B.V. Teva Pharmaceutical Works Private Limited Company

  • It is used to treat symptoms of overactive bladder syndrome, such as difficulty controlling urination, a sudden urge to urinate, or frequent urination.

    Form: tablets, film-coated

    Active substance Dosage
    tolterodine tartrate 1 mg

    ATC: G04BD07

    Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.

  • It is used in the treatment of symptoms of overactive bladder syndrome. It helps people who have difficulty controlling urination, experience a sudden urge to go to the toilet, or use the toilet very frequently.

    Form: tablets, film-coated

    Active substance Dosage
    tolterodine tartrate 2 mg

    ATC: G04BD07

    Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.

  • It is used to treat symptoms of overactive bladder syndrome, such as a sudden urge to urinate quickly, frequent urination, or inability to control urination.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 2 mg

    ATC: G04BD07

    Manufacturer: Pharmathen International S.A.

  • It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to urinate quickly, frequent urination, or urinary incontinence.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 4 mg

    ATC: G04BD07

    Manufacturer: Pharmathen International S.A.

  • It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to use the toilet quickly, frequent use of the toilet, or an inability to control urination.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 2 mg

    ATC: G04BD07

    Manufacturer: Pharmathen International S.A.

  • It is used to treat the symptoms of overactive bladder syndrome, such as a sudden urge to urinate, frequent urination, or urinary incontinence.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 4 mg

    ATC: G04BD07

    Manufacturer: Pharmathen S.A.

  • It is used to treat the symptoms of an overactive bladder, which is a situation where the patient cannot control urination or feels a sudden urge to use the toilet frequently.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 2 mg

    ATC: G04BD07

    Manufacturer: Pharmathen International S.A.

  • It is used to treat symptoms of an overactive bladder, such as a sudden urge to urinate, frequent urination, or loss of bladder control.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 4 mg

    ATC: G04BD07

    Manufacturer: Pharmathen International S.A.

  • It is used to treat symptoms of overactive bladder syndrome, such as urinary incontinence, a sudden urge to urinate quickly, or increased frequency of urination.

    Form: capsules, extended release, hard

    Active substance Dosage
    tolterodine tartrate 4 mg

    ATC: G04BD07

    Manufacturer: Pharmaten International S.A.